An extremely rare aggressive neoplasm choriocarcinoma of ovary: a case report

Sangeeta Raman Jogi; Dipika Singh; Rachna Jain; Anju Garhewal

doi:10.18203/2320-1770.ijrcog20242093

Authors

Sangeeta Raman Jogi Department of Obstetrics and Gynecology, Chhattisgarh Institute of Medical Science, Bilaspur, Chattisgarh, India
Dipika Singh Department of Obstetrics and Gynecology, Chhattisgarh Institute of Medical Science, Bilaspur, Chattisgarh, India
Rachna Jain Department of Obstetrics and Gynecology, Chhattisgarh Institute of Medical Science, Bilaspur, Chattisgarh, India
Anju Garhewal Department of Obstetrics and Gynecology, Chhattisgarh Institute of Medical Science, Bilaspur, Chattisgarh, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20242093

Keywords:

Choriocarcinoma, Neoplasm, Pregnancy

Abstract

Choriocarcinoma of ovary is an extremely rare neoplasm. Based on its origin it is gestational and non-gestational. Gestational ovarian choriocarcinoma can arise from an ectopic pregnancy or present as a metastasis from a uterine or tubal choriocarcinoma. Its incidence is 1 in 369 million pregnancies whereas non-gestational ovarian choriocarcinoma originates from germ cells and its incidence is<0.6% of ovarian germ cell neoplasm. A case report of a 26-year-old female came to our hospital with complain of pain in her abdomen with an abdominal mass for 20 days with a history of D&C 1 month back for early pregnancy of 8 weeks, here we investigated and diagnosed her as a neoplastic ovarian mass. Then the patient was taken for exploratory laprotomy with TAH with retroperitoneal mass removal with right ovarian mass removal with sigmoidectomy with colostomy with mesenteric LN sampling. Ovarian choriocarcinoma is difficult to diagnose due to its nonspecific presentation. It is commonly diagnosed after surgical management of abdominal mass. The definitive diagnosis can only be confirmed after molecular genetic analysis. Gestational choriocarcinoma is extremely rare aggressive neoplasm with metastatic transformation having poor prognosis.

Metrics

Metrics Loading ...

References

Tarney CM, Tian C, Craig ER, Crothers BA, Chan JK, Gist GD, et al. Relative effects of age, race, and stage on mortality in gestational choriocarcinoma. Int J Gynecol Cancer. 2018;28(2):338-45.

WHO. Fact sheet: Gestational trophoblastic diseases. Available at: https://iris.who.int/bitstream/handle/10665/39169/WHO_TRS_692.pdf;jsessionid=19C4840A3B6EF79B32F1E8B06518057F?sequence=1. Accessed on 10 July 2024.

Malik R, Verma M, Chauhan M, Sinha P. Choriocarcinoma of the ovary masquerading as ectopic pregnancy. Gynecol Minim Invasive Ther. 2022;11(4):247-9.

Whynott RM. Primary ovarian choriocarcinoma masquerading as ruptured ectopic pregnancy in an HIV positive woman. 2017;3:5-9.

Mangla M, Palo S, Kanikaram P, Kaur H. Non-gestational choriocarcinoma: unraveling the similarities and distinctions from its gestational counterpart. Int J Gynecol Cancer. 2024;34(6):926-34.

Cronin S, Ahmed N, Craig AD, King S, Huang M, Chu CS, et al. Non-gestational ovarian choriocarcinoma: a rare ovarian cancer subtype. Diagnostics (Basel). 2022;12(3):560.

Mood NI, Samadi N, Rahimi-Moghaddam P, Sarmadi S, Eftekhar Z, Yarandi F. Pure ovarian choriocarcinoma: report of two cases. J Res Med Sci. 2009;14(5):327-30.

Liu X, Zhang X, Pang Y, Ma Y, Zhang X, Liu P. Clinicopathological factors and prognosis analysis of 39 cases of non-gestational ovarian choriocarcinoma. Arch. Gynecol. Obstet. 2020;301:901-12.